TABLE 1.
No Adjuvant Therapy (n = 1075) | Adjuvant Therapy (n = 1333) | Total (n = 2408) | |
---|---|---|---|
Sex | |||
Male | 506 (47.1) | 724 (54.3) | 1230 (51.1) |
Female | 569 (52.9) | 609 (45.7) | 1178 (48.9) |
Age group, y | |||
18–34 | 68 (6.3) | 9 (0.7) | 77 (3.2) |
35–44 | 106 (9.9) | 82 (6.2) | 188 (7.8) |
45–54 | 274 (25.5) | 349 (26.2) | 623 (25.9) |
55–64 | 627 (58.3) | 893 (67.0) | 1520 (63.1) |
Charlson Co-morbidity Index | |||
≤2 | 568 (52.8) | 508 (38.1) | 1076 (44.7) |
>2 | 507 (47.2) | 825 (61.9) | 1332 (55.3) |
Procedure type | |||
Proximal pancreatectomy | 15 (1.4) | 13 (1.0) | 28 (1.2) |
Distal pancreatectomy | 418 (38.9) | 229 (17.2) | 647 (26.9) |
Radical antegrade pancreaticosplenectomy | 14 (1.3) | 12 (0.9) | 26 (1.1) |
Other partial pancreatectomy | 60 (5.6) | 22 (1.7) | 82 (3.4) |
Total pancreatectomy | 42 (3.9) | 58 (4.4) | 100 (4.2) |
Whipple | 526 (48.9) | 999 (74.9) | 1525 (63.3) |
Complications hospitalization | |||
0 | 783 (72.8) | 1017 (76.3) | 1800 (74.8) |
1 | 266 (24.7) | 293 (22.0) | 559 (23.2) |
2 or more | 26 (2.4) | 23 (1.7) | 49 (2.0) |
Nodal involvement | |||
No | 838 (78.0) | 754 (56.6) | 1592 (66.1) |
Yes | 237 (22.0) | 579 (43.4) | 816 (33.9) |
Neoadjuvant therapy | |||
No | 942 (87.6) | 1051 (78.8) | 1993 (82.8) |
Yes | 133 (12.4) | 282 (21.2) | 415 (17.2) |